Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Ferrostatin-1

SKU: orb1225231

Description

Ferrostatin-1 is a potent ferroptosis inhibitor with IC50 of 33 nM, inhibits erastin-induced ferroptosis in HT-1080 cells with EC50 of 60 nM; prevents erastin-induced accumulation of cytosolic and lipid ROS, does not inhibit ERK phosphorylation or arrest the proliferation of HT-1080 cells.(In Vitro):Ferrostatin-1 prevents erastin-induced accumulation of cytosolic and lipid ROS. Ferrostatin-1 prevents glutamate-induced neurotoxicity in organotypic rat brain slices.Ferrostatin-1 (2 μM; 24 h) prevents Glutamate (5 mM)-induced neurotoxicity in a rat organotypic hippocampal slice culture (OHSC).Ferrostatin-1 inhibits lipid peroxidation, but not mitochondrial reactive oxygen species formation or lysosomal membrane permeability.Ferrostatin-1 inhibits cell death in cellular models of Huntington's disease (HD), periventricular leukomalacia (PVL), and kidney dysfunction.Ferrostatin-1 (1 μM; 6 h) inhibits the oxidative destruction of unsaturated fatty acids in HT-1080 cells, thus increases the number of healthy medium spiny neurons (MSNs).\n(In Vivo):Ferrostatin-1 (5 mg/kg; ip; single dose, 30 min before glycerol injection) improves renal function in mice with rhabdomyolysis, whereas no beneficial effects were observed with the pan-caspase inhibitor zVAD or in RIPK3-deficient mice.Ferrostatin-1 (0.8 mg/kg; tail vein injection) effectively alleviates LPS-induced induced acute lung injury (ALI).Ferrostatin-1 (i.p.; 5 mg/kg; C57BL/6J mice) improves renal function in mice with rhabdomyolysis.

Images & Validation

Key Properties

CAS Number347174-05-4
MW262.353
Purity>98% (HPLC)
FormulaC15H22N2O2
SMILESO=C(OCC)C1=CC=C(NC2CCCCC2)C(N)=C1
TargetFerroptosis
SolubilityDMSO: 26.2 mg/mL (100 mM); Ethanol: 26.2 mg/mL (100 mM) ( < 1 mg/ml refers to the product slightly soluble or insoluble )

Bioactivity

In Vivo
Animal model: Male C57BL/6 mice (LPS-induced ALI). Dosage: 0.8 mg/kg. Administration: Tail vein injection. Result: Exerted therapeutic action against LPS-induced ALI.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

Ferrostatin 1

Similar Products

  • Ferrostatin-1 [orb1300714]

    >98%

    347174-05-4

    262.35

    C15H22N2O2

    5 mg, 25 mg
  • Ferrostatin-1 diyne [orb2802507]

    2226204-90-4

    298.38

    C18H22N2O2

    10 mg, 1 mg, 5 mg, 25 mg
  • Erastin2 [orb1694134]

    99.87% (May vary between batches)

    1695533-44-8

    623.14

    C36H35ClN4O4

    50 mg, 100 mg, 5 mg, 1 mg, 10 mg, 25 mg, 1 ml x 10 mM (in DMSO)
  • GPX4 9i [orb3027433]

    3035800-33-7

    540.66

    C29H24N4O3S2

    50 mg, 10 mg
  • JKE-1716 [orb3177649]

    2421118-05-8

    451.3

    C20H20Cl2N4O4

    25 mg, 10 mg, 1 mg, 5 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Protocol Information

Available Sizes

Select a size below

5 mg
$ 100.00
10 mg
$ 140.00
25 mg
$ 280.00
50 mg
$ 480.00
200 mg
$ 790.00
500 mg
$ 1,260.00